Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

French drugmaker Sanofi’s confirmation yesterday that it plans to sell a controlling stake in its over-the-counter unit to a ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

Global investment firm CD&R announced an open offer to buy a 26% stake in Sanofi Consumer Healthcare India for Rs 2,983 crore ...

Miracle cures are few and far between. The best one can hope for is partial relief. So it is with Sanofi’s consumer health split. The French pharma group’s sale of a majority 50 per cent stake in its ...

The Biden administration proposes a rule allowing women with private insurance to access over-the-counter birth control pills ...

Global investment firm CD&R on Monday announced an open offer to acquire a 26 per cent stake in Sanofi Consumer Healthcare India Ltd for an aggregate of up to Rs 2,983 crore. The development follows ...

An international investment company, CD&R, has announced plans to acquire a 26% stake in Sanofi Consumer Healthcare India Ltd ...

By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% ...

French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...